Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 819

1.

Parent decision-making around the genetic testing of children for germline TP53 mutations.

Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE.

Cancer. 2014 Sep 15. doi: 10.1002/cncr.29027. [Epub ahead of print]

PMID:
25223899
[PubMed - as supplied by publisher]
2.

Exploring variations in functional connectivity of the resting state default mode network in mild traumatic brain injury.

Nathan DE, Yeh PH, French LM, Harper JF, Liu W, Wolfowitz RD, Wang BQ, Graner JL, Oakes T, Riedy G.

Brain Connect. 2014 Sep 15. [Epub ahead of print]

PMID:
25222050
[PubMed - as supplied by publisher]
3.

Effect of phosphodiesterase inhibition on insulin resistance in obese individuals.

Ho JE, Arora P, Walford GA, Ghorbani A, Guanaga DP, Dhakal BP, Nathan DI, Buys ES, Florez JC, Newton-Cheh C, Lewis GD, Wang TJ.

J Am Heart Assoc. 2014 Sep 11;3(5). pii: e001001. doi: 10.1161/JAHA.114.001001.

PMID:
25213566
[PubMed - in process]
Free Article
4.

Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor.

Kochenderfer JN, Dudley ME, Kassim SH, Somerville RP, Carpenter RO, Stetler-Stevenson M, Yang JC, Phan GQ, Hughes MS, Sherry RM, Raffeld M, Feldman S, Lu L, Li YF, Ngo LT, Goy A, Feldman T, Spaner DE, Wang ML, Chen CC, Kranick SM, Nath A, Nathan DA, Morton KE, Toomey MA, Rosenberg SA.

J Clin Oncol. 2014 Aug 25. pii: JCO.2014.56.2025. [Epub ahead of print]

PMID:
25154820
[PubMed - as supplied by publisher]
5.

Glycemic Control After Hospital Discharge in Insulin-Treated Type 2 Diabetes: A Randomized Pilot of Daily Remote Glucose Monitoring.

Wei NJ, Nathan DM, Wexler DJ.

Endocr Pract. 2014 Aug 22:1-18. [Epub ahead of print]

PMID:
25148814
[PubMed - as supplied by publisher]
6.

Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM, Curtis JM, Egan C, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Hazuda HP, Hill JO, Hire D, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Kitabchi AE, Knowler WC, Kriska A, Lewis CE, Miller M, Montez MG, Murillo A, Nathan DM, Nyenwe E, Patricio J, Peters AL, Pi-Sunyer X, Pownall H, Redmon JB, Rushing J, Ryan DH, Safford M, Tsai AG, Wadden TA, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Sep;37(9):2548-56. doi: 10.2337/dc14-0093.

PMID:
25147253
[PubMed - in process]
7.

Hereditary xerocytosis revisited.

Archer NM, Shmukler BE, Andolfo I, Vandorpe DH, Gnanasambandam R, Higgins JM, Rivera A, Fleming MD, Sachs F, Gottlieb PA, Iolascon A, Brugnara C, Alper SL, Nathan DG.

Am J Hematol. 2014 Jul 5. doi: 10.1002/ajh.23799. [Epub ahead of print] No abstract available.

PMID:
25044010
[PubMed - as supplied by publisher]
8.

Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.

Rutter MK, Sullivan LM, Fox CS, Wilson PW, Nathan DM, Vasan RS, D'Agostino RB Sr, Meigs JB.

Metab Syndr Relat Disord. 2014 Sep;12(7):372-80. doi: 10.1089/met.2013.0148. Epub 2014 Jul 9.

PMID:
25007010
[PubMed - in process]
9.

How best to teach developmental assessment? A single-blinded randomised study.

Feyereislova S, Nathan D.

Arch Dis Child. 2014 Jun 23. pii: archdischild-2013-305536. doi: 10.1136/archdischild-2013-305536. [Epub ahead of print]

PMID:
24958795
[PubMed - as supplied by publisher]
10.

Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, Balliro C, Hillard MA, Nathan DM, Damiano ER.

N Engl J Med. 2014 Jul 24;371(4):313-25. doi: 10.1056/NEJMoa1314474. Epub 2014 Jun 15.

PMID:
24931572
[PubMed - indexed for MEDLINE]
11.

Connecting combat-related mild traumatic brain injury with posttraumatic stress disorder symptoms through brain imaging.

Costanzo ME, Chou YY, Leaman S, Pham DL, Keyser D, Nathan DE, Coughlin M, Rapp P, Roy MJ.

Neurosci Lett. 2014 Aug 8;577:11-5. doi: 10.1016/j.neulet.2014.05.054. Epub 2014 Jun 4.

PMID:
24907686
[PubMed - in process]
12.

A Comparative Effectiveness Analysis of Three Continuous Glucose Monitors: The Navigator, G4 Platinum, and Enlite.

Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ.

J Diabetes Sci Technol. 2014 Apr 21. pii: 1932296814532203. [Epub ahead of print]

PMID:
24876423
[PubMed - as supplied by publisher]
13.

Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.

Rubin RR, Wadden TA, Bahnson JL, Blackburn GL, Brancati FL, Bray GA, Coday M, Crow SJ, Curtis JM, Dutton G, Egan C, Evans M, Ewing L, Faulconbridge L, Foreyt J, Gaussoin SA, Gregg EW, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Knowler WC, Lang W, Lewis CE, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Rejeski WJ, Rosenthal RH, Ruelas V, Toledo K, Van Dorsten B, Vitolins M, Williamson D, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Jun;37(6):1544-53. doi: 10.2337/dc13-1928.

PMID:
24855155
[PubMed - in process]
14.

Musculoskeletal complications in type 1 diabetes.

Larkin ME, Barnie A, Braffett BH, Cleary PA, Diminick L, Harth J, Gatcomb P, Golden E, Lipps J, Lorenzi G, Mahony C, Nathan DM; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

Diabetes Care. 2014 Jul;37(7):1863-9. doi: 10.2337/dc13-2361. Epub 2014 Apr 10.

PMID:
24722493
[PubMed - in process]
15.

Understanding the importance of natural neuromotor strategy in upper extremity neuroprosthetic control.

Nathan DE, Prost RW, Guastello SJ, Jeutter DC.

Int J Bioinform Res Appl. 2014;10(2):217-34. doi: 10.1504/IJBRA.2014.059521.

PMID:
24589839
[PubMed - in process]
16.

The role of adenosine signaling in sickle cell therapeutics.

Field JJ, Nathan DG, Linden J.

Hematol Oncol Clin North Am. 2014 Apr;28(2):287-99. doi: 10.1016/j.hoc.2013.11.003. Epub 2014 Jan 18.

PMID:
24589267
[PubMed - in process]
17.

Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease.

Lo C, Lui M, Ranasinha S, Teede HJ, Kerr PG, Polkinghorne KR, Nathan DM, Zheng H, Zoungas S.

Diabetes Res Clin Pract. 2014 Apr;104(1):84-91. doi: 10.1016/j.diabres.2014.01.020. Epub 2014 Feb 3.

PMID:
24573088
[PubMed - in process]
18.

Empirically establishing blood glucose targets to achieve HbA1c goals.

Wei N, Zheng H, Nathan DM.

Diabetes Care. 2014 Apr;37(4):1048-51. doi: 10.2337/dc13-2173. Epub 2014 Feb 10.

PMID:
24513588
[PubMed - in process]
19.

Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.

El-Khatib FH, Russell SJ, Magyar KL, Sinha M, McKeon K, Nathan DM, Damiano ER.

J Clin Endocrinol Metab. 2014 May;99(5):1701-11. doi: 10.1210/jc.2013-4151. Epub 2014 Jan 31.

PMID:
24483160
[PubMed - indexed for MEDLINE]
20.

Self-reported autoimmune disease by sex in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.

Buschur E, Sarma AV, Pietropaolo M, Dunn RL, Braffett BH, Cleary PA, Cowie C, Larkin ME, Wessells H, Nathan DM, Kim C; DCCT/EDIC Research Group.

Diabetes Care. 2014 Feb;37(2):e28-9. doi: 10.2337/dc13-1890. No abstract available.

PMID:
24459159
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk